The Future of Oncology: Key Takeaways from ASCO | Biotech Bulls & Breakthroughs Podcast

Описание: In this episode, John Gagliano and Sheff discuss the recent ASCO conference, its significance in the oncology space, and key takeaways from the event. They delve into the importance of biotech conferences for investors, analyze oncology companies and their drug development strategies, and explore investment strategies focusing on smaller biotech firms. The conversation also touches on the role of AI in drug development and highlights current watchlist stocks with upcoming catalysts.

In this episode:
🔹 ASCO Recap & Conferences
🔹 AI in drug development
🔹 M&A Biotech Activity

🧭 Track upcoming catalysts: https://www.biopharmcatalyst.com/cale...
🎧 Listen to more episodes: https://www.biopharmcatalyst.com/podcast
📈 See Sheff’s Watchlist: https://www.biopharmcatalyst.com/shef...

📲 Follow BioPharmCatalyst: https://x.com/BPharmCatalyst
📲 Follow Sheff: https://x.com/SheffStation

Sheff is proud to support the Northwest Association for Blind Athletes. Join us in empowering life-changing opportunities for visually impaired youth and adults through sports and community engagement. You can support this as well in the link below:
Support NWABA: https://nwaba.org/support/other-ways-...

Disclaimer: BioPharmCatalyst is not a registered investment advisory firm and the views on this podcast are not to intended to be financial advice. The stocks discussed in this podcast may be held in personal or other investment accounts. This content is for informational purposes only and should not be considered investment advice. Always do your own research before making any investment decisions.

Chapters
00:00 Introduction and Overview of ASCO Conference
02:23 Significance of Conferences in Biotech Investing
05:01 Key Takeaways from ASCO 2023
12:07 Analyzing Oncology Companies and Drug Development
14:04 Investment Strategies in Biotech
18:58 The Role of AI in Biotech
22:16 Sheff's Watchlist and Upcoming Catalysts